BACKGROUND AND PURPOSE: Brain atrophy is an important surrogate for brain reserve, the capacity of the brain to cope with acquired injuries such as acute stroke. It is unclear how well atrophy measurements on MR imaging can be reproduced using NCCT imaging. We aimed to compare pragmatic atrophy measures on NCCT with MR imaging in patients with acute ischemic stroke. MATERIALS AND METHODS: This is a post hoc analysis, including baseline NCCT and 24-hour follow-up MR imaging data from the Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1) trial. Cortical atrophy was measured using the global cortical atrophy scale, and subcortical atrophy was measured using the intercaudate distan...
To our knowledge, this is the largest study evaluating relationships between 3T Magnetic Resonance I...
Introduction: Cerebral atrophy is a compound measure of the neurodegenerative component of multiple ...
Background and Purpose - Individual markers of cerebral small vessel disease and cerebral atrophy ex...
BACKGROUND AND PURPOSE: Brain atrophy is an important surrogate for brain reserve, the capacity of t...
BACKGROUND AND OBJECTIVES: Brain frailty may impair the ability of acute stroke patients to cope wit...
Measurement of brain atrophy has been proposed as a Surrogate marker in MS and degenerative dementia...
Background: Brain atrophy is suggested to impair the potential for functional recovery after acute i...
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous sy...
Introduction: Cerebral atrophy after stroke is associated with poor functional outcome. The predicti...
OBJECTIVE: Brain atrophy is part of the pathophysiology of Multiple Sclerosis (MS), correlates with ...
BACKGROUND AND PURPOSE:Brain atrophy can be regarded as an end-organ effect of cumulative cardiovasc...
BACKGROUND AND PURPOSE: Methods have not been well developed and tested to predict the extent of rem...
OBJECTIVES: To assess whether volumetric cerebrospinal fluid (CSF) MRI can be used as a surrogate fo...
BACKGROUND AND PURPOSE: Brain atrophy is a proposed marker of disease progression in multiple sclero...
Background: Brain atrophy is one of the features of the dementive diseases, but also of other neurod...
To our knowledge, this is the largest study evaluating relationships between 3T Magnetic Resonance I...
Introduction: Cerebral atrophy is a compound measure of the neurodegenerative component of multiple ...
Background and Purpose - Individual markers of cerebral small vessel disease and cerebral atrophy ex...
BACKGROUND AND PURPOSE: Brain atrophy is an important surrogate for brain reserve, the capacity of t...
BACKGROUND AND OBJECTIVES: Brain frailty may impair the ability of acute stroke patients to cope wit...
Measurement of brain atrophy has been proposed as a Surrogate marker in MS and degenerative dementia...
Background: Brain atrophy is suggested to impair the potential for functional recovery after acute i...
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous sy...
Introduction: Cerebral atrophy after stroke is associated with poor functional outcome. The predicti...
OBJECTIVE: Brain atrophy is part of the pathophysiology of Multiple Sclerosis (MS), correlates with ...
BACKGROUND AND PURPOSE:Brain atrophy can be regarded as an end-organ effect of cumulative cardiovasc...
BACKGROUND AND PURPOSE: Methods have not been well developed and tested to predict the extent of rem...
OBJECTIVES: To assess whether volumetric cerebrospinal fluid (CSF) MRI can be used as a surrogate fo...
BACKGROUND AND PURPOSE: Brain atrophy is a proposed marker of disease progression in multiple sclero...
Background: Brain atrophy is one of the features of the dementive diseases, but also of other neurod...
To our knowledge, this is the largest study evaluating relationships between 3T Magnetic Resonance I...
Introduction: Cerebral atrophy is a compound measure of the neurodegenerative component of multiple ...
Background and Purpose - Individual markers of cerebral small vessel disease and cerebral atrophy ex...